无数据
Scan for full text
Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China
Institute of Hematology, Zhejiang University, Hangzhou 310058, China
1.Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China
2.Institute of Hematology, Zhejiang University, Hangzhou 310058, China
Published: 2020-01 ,
Received: 27 June 2019 ,
Accepted: 30 August 2019
Cite this article
He Huang, Heng-wei Wu, Yong-xian Hu. Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma. [J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology) 21(1):29-41(2020)
He Huang, Heng-wei Wu, Yong-xian Hu. Current advances in chimeric antigen receptor T-cell therapy for refractory/relapsed multiple myeloma. [J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology) 21(1):29-41(2020) DOI: 10.1631/jzus.B1900351.
0
Views
0
Downloads
4
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution